DR-TB Management

DR-TB Management

Invest in supporting Drug Resistant TB management. Program is adopting new solutions to treat DR-TB, support in rollout of new approaches in diagnosis and treatment of DR-TB as per the new guidelines of the program.

Resistance to anti-TB drugs can occur when these drugs are misused or mismanaged. Examples include when patients do not complete their full course of treatment; when there is wrong drug combination, the wrong dose, or length of time for taking the drugs ; when the supply of drugs is not always available; or when the drugs are of poor quality.

Problem Statement

High cost and limited availability of proper medication is a challenge in managing and treating DR-TB. Often, patients experience adverse effects from the drugs and tend to interrupt their treatment, which further decrease their chances of favorable outcome.

In some cases, extensively drug-resistant TB (XDR-TB) may develop with additional resistance to more anti- TB drugs, and this responds to even fewer available medicines.

In order to prevent these challenges, it is best to control drug-resistant TB by: 

  • Successfully treating every TB case the first time around.
  • Providing immediate access to appropriate and complete diagnosis for early management.
  • Ensuring adequate infection control in all settings, including at home and hospitals, to prevent spread.
  • Ensuring appropriate use of recommended anti-TB drugs

Corporate sector with its reach among workers, communities along with expertise and resources can play a vital role in fulfilling the vision of a TB Free India. Corporates can facilitate early diagnosis and treatment of TB cases in the community which is an important step in TB elimination. These help in mitigating the risks of transmission of disease to others, poor health outcomes; and social and economic hardships of the patient and their family.

Collaboration Avenues

Inviting applications for Independent consultants

Inviting applications for Independent consultants

Complement the Government efforts by investing into meeting the existing gap in DR-TB healthcare services.

Show Interest
Supporting pre-treatment evaluation for patients

Supporting pre-treatment evaluation for patients

Invest in establishing effective pre-treatment evaluation and during treatment assessment support for patients as part of CSR initiative.

Show Interest
Supporting Patient Transport

Supporting Patient Transport

Contribute to facilitate free of cost travel for TB patients to diagnostic centres and enable timely detection of TB among

Show Interest
Institutional Strengthening for DR-TB Care

Institutional Strengthening for DR-TB Care

Complement the Government efforts by investing into meeting the existing gap in DR-TB healthcare services.

Show Interest

Contact Us

Contact us to know more and understand how can you contribute towards the cause of TB-Free India by 2025.

Invest to Eliminate TB

Despite TB being a curable disease and free of cost treatment being provided by the Government, India continues to have the highest incidence of TB in the world along with highest TB mortality. Prime Minister Mr Narendra Modi committed to eliminate TB in India by 2025.  It is an ambitious target and there is a need for increased investments and partnerships by all sectors including the corporate sector to contribute to the goal of making India TB free. These partnerships will not only save lives but also help your brand gain the visibility it deserves as it cares for its people and communities,  and support interventions with measurable outcomes.

Delay in accurate diagnosis of tuberculosis in India is also due to untrained first line of contact, be it allopaths or alternative medicine.